Literature DB >> 15637040

Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy.

P Rossi, A L Demoux, B Granel, D Bagnères, S Bonin-Guillaume, Y Frances.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15637040     DOI： 10.1093/rheumatology/keh463

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Autoimmune haemolytic anaemia associated with mantle cell lymphoma.

Authors:  Heather E Eve; Simon A J Rule
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

2.  Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia.

Authors:  Brigitte Granel; Pascal Rossi; Fanny Bernard; Isabelle Dettori; Regis Costello; Anne Laurence Demoux; Denis Bagneres; Pierre Lafforgue; Yves Frances
Journal:  BMJ Case Rep       Date:  2009-03-06

Review 3.  Rituximab therapy for membranous nephropathy: a systematic review.

Authors:  Andrew S Bomback; Vimal K Derebail; Julie G McGregor; Abhijit V Kshirsagar; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 8.237

4.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

Review 5.  Membranous nephropathy in the older adult: epidemiology, diagnosis and management.

Authors:  Jeroen K J Deegens; Jack F M Wetzels
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.